Last reviewed · How we verify

NCT04414332: RAPID

Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry

Completed Last updated 4 June 2020
What this trial tests

trial testing Data collection only in Venous Thromboembolic Disease in 234 participants. Completed in 27 February 2020.

Timeline
1 September 2015
Primary endpoint
27 February 2020
27 February 2020

Quick facts

Lead sponsorUniversity of California, Los Angeles
StatusCompleted
Study typeOBSERVATIONAL
Enrollment234
Start date1 September 2015
Primary completion27 February 2020
Estimated completion27 February 2020

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Los Angeles

Who can join

18 and older, any sex, with Venous Thromboembolic Disease or Deep Venous Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Venous thromboembolic disease is a significant cause of morbidity and mortality. The purpose of the RAPID registry is to collect information on the Angiovac procedure and Angiovac device used in the treatment of deep venous thrombosis (DVT), right heart pathology and pulmonary embolism.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Procedural outcomes associated with use of the AngioVac System for right heart thrombi: A safety report from RAPID registry data.
    Moriarty JM, Liao M, Kim GHJ, Yang E, et al · · 2022 · cited 14× · PMID 35176918 · DOI 10.1177/1358863x211073974

Verify or expand the search:

Other trials of Data collection only

Trials testing the same drug.

Other recruiting trials for Venous Thromboembolic Disease

Currently open trials in the same condition.

Other University of California, Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04414332.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing